glp-1 dementia news

glp-1 dementia news Adults whose type 2 diabetes was treated with receptor agonists were more likely to develop cognitive impairment over 10 years than their counterparts not treated with GLP-1 agents, a propensity-matched retrospective Could diabetes and weight loss

Name: glp-1 dementia news Adults whose type 2 diabetes was treated with receptor agonists were more likely to develop cognitive impairment over 10 years than their counterparts not treated with GLP-1 agents, a propensity-matched retrospective Could diabetes and weight loss
Brand: actil.am
SKU: 83098880963
Price: 27.95 USD
Availability: InStock
Rating: 4.2556 (10 reviews)

SKU: 83098880963

4.3

USD27.95 USD65.95

Pay in 4 interest-free payments of $6.99 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 30 - Sep 4

Description

3 Expert Rev Clin Pharmacol Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria (Minder & Schneider-Yin, 2014)Reviews the -MSH receptor-mediated mechanism, the rationale for afamelanotide in protoporphyria, and the phase II/III and safety results, concluding the risk-benefit profile is favorable in this indication